Reactivation of the embryonic ζ-globin gene ameliorates severe forms of α-thalassemia.

Reactivating the silenced embryonic ζ-globin gene restores therapeutic hemoglobin levels in severe α-thalassemia models, including lethal forms like Hb Bart's hydrops fetalis.

• Why it matters: Severe α-thalassemia causes life-threatening anemia, and current treatments are limited to transfusions or stem cell transplants, highlighting the need for innovative therapies.
• What they did: Researchers identified key regulatory elements that silence ζ-globin in erythroid cells and developed gene-editing methods to reactivate its expression, testing these in mouse models and patient-derived cells.
• The result: The strategy rescued lethal prenatal conditions in mice and elevated ζ-globin levels beyond those in models, enabling potential therapeutic benefits for severe α-thalassemia patients.